Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McKenna Mark C.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Jane
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(3.4%),Peter Kolchinsky(3.4%), etc.
Apogee Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-DRIEHAUS CAPITAL MANAGEMENT LLC(5.63%)
Apogee Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(2.22%),Deep Track Biotechnology Master Fund, Ltd.(2.22%), etc.
Apogee Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(16.672%),Abigail P. Johnson(16.672%)
Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
Apogee Therapeutics | 10-Q: Q3 2024 Earnings Report
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.6%)